Tredegar Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TG research report →
Price Chart
About the company
Tredegar Corporation, functioning through its affiliated entities, is a global producer and purveyor of key materials, including aluminum extrusions, as well as polyethylene (PE) and polyester films, reaching customers both in the United States and abroad. The company's operations are categorized into three principal divisions: Aluminum Extrusions, PE Films, and Flexible Packaging Films. The Aluminum Extrusions division crafts custom-fabricated and finished aluminum extrusions in soft-alloy and medium-strength formulations.
- CEO
- Arijit DasGupta
- IPO
- 1989
- Employees
- 1,700
- HQ
- Richmond, VA, US
Get TickerSpark's AI analysis on TG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $274.30M
- P/E
- 8.19
- PEG
- 0.04
- P/S
- 0.35
- P/B
- 1.20
- EV/EBITDA
- 4.21
- Div Yield
- 0.00%
- Gross Margin
- 14.44%
- Op Margin
- 4.33%
- Net Margin
- 4.26%
- ROE
- 15.30%
- ROIC
- 9.28%
Latest fiscal year · YoY change
- Revenue
- $722.86M+20.9%
- Gross Profit
- $109.41M+13.9%
- Op Income
- $27.86M
- Net Income
- $33.48M+151.8%
- EPS
- $0.96+151.1%
- OCF Growth
- +29.3%
- FCF Growth
- +41.0%
- 52W High
- $10.53
- 52W Low
- $6.25
- 50D MA
- $7.79
- 200D MA
- $8.13
- Beta
- 0.78
- RSI (14)
- 50
- Avg Volume
- 168.68K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Tredegar said 2014 was a mixed year: Film Products struggled with Brazil operational issues and pricing pressure, while Bonnell delivered a breakout year and management expects 2015 to be an execution year.· March 2, 2015
- Film Products had weak 2014 results, with net sales down 7% to $579 million and operating profit down 18% to $58 million.
- Bonnell was the bright spot: 2014 net sales rose $35 million to $344 million and operating profit increased 40% to $26 million.
- Management said Brazil flexible packaging operational inefficiencies were resolved by year-end, while the new flexible packaging line ramped faster than expected after an $80 million investment.
- 2015 guidance calls for difficult market conditions in flexible packaging, especially in the first half, but improved results later in the year as new products and volume ramp.
- The company kept focusing on capital discipline, with 2014 operating cash flow just above $50 million, capex nearly $45 million, and net debt at $87 million.
Tredegar reported fourth-quarter diluted EPS from continuing operations of $0.40 and full-year diluted EPS from continuing operations of $1.11. Excluding special items, EPS from ongoing operations was $0.23 in the fourth quarter and $1.13 for the full year, versus $1.15 in 2013. Film Products full-year net sales were $579 million, down 7%, and operating profit was $58 million, down 18%; Bonnell full-year net sales were $344 million, up $35 million, and operating profit was $26 million, up 40%. On the full year, noncash pension expense was $6.7 million, effective tax rate was 35% versus 31% in 2013, cash flow from operations was just above $50 million, capital spending was nearly $45 million, net debt was $87 million, and debt to adjusted EBITDA was 1.42x. For 2015, management expects noncash pension expense of approximately $12.3 million, an effective tax rate around 35%, capital spending of just over $40 million, Film Products adjusted EBITDA margin to move toward 17% to 18% by 2016, Bonnell EBITDA margin to be 10% to 11%, and return on invested capital to reach 11% to 12% in 2016.
Nancy Taylor framed 2014 as a “mixed” year and emphasized that Tredegar has been making deliberate investments to support long-term growth. She said the company is now positioned to benefit as those investments wind down, with 2015 becoming a year of execution and 2016 the point when returns should become more visible. Her tone was constructive but measured: she acknowledged the setbacks in Brazil and the difficult PET film market, while highlighting customer response to new products like ForceField PEARL and growth opportunities in automotive and non-residential construction.
Kevin O’Leary focused on the earnings bridge and balance-sheet/return metrics. He said ongoing EPS was $1.13 for 2014 versus $1.15 in 2013, with combined segment operating profit $5.5 million below 2013, noncash pension expense of $6.7 million (down $7 million), and a 35% tax rate versus 31% last year; he also flagged a 2015 pension expense step-up to about $12.3 million due mainly to a lower discount rate of 4.17%. On cash and capital allocation, he noted operating cash flow just above $50 million, capex nearly $45 million in 2014, planned 2015 capex just over $40 million, and net debt of $87 million with debt/adjusted EBITDA of 1.42x. He said 2014 ROIC was 8.5% and reiterated the 11% to 12% ROIC target for 2016.
In Q&A, Drake Johnstone asked whether a $4.4 million fourth-quarter hit in Film Products was one-time and whether that implied a Q1 rebound; Kevin O’Leary clarified that the $4.4 million was an operational impact, not simply a one-off, though roughly $2 million of inventory adjustments and about $2 million of efficiency spending in the second half should not recur in 2015. Drake also asked about capital spending stepping down after 2015, and management said it did not expect anything much beyond the $40 million range unless attractive opportunities arose. Mario Gabelli asked about the value of the Kaleo/Intelliject investment; management said the balance-sheet value was about $39 million at year-end, representing just under 20% ownership, and that it was not consolidated. He also asked about pension cash contributions and receivables, and management said pension cash in was roughly $2 million in 2014 and expected to be about the same in 2015, while the receivables increase reflected higher Q4 revenue rather than an issue.
The bull case from this call is that Tredegar believes it has already fixed the biggest self-inflicted issues in Brazil and is entering 2015 with better operations, new capacity, and new products. Management pointed to strong customer response to PEARL and other product launches, plus Bonnell’s continued momentum in automotive, anodizing, and non-residential construction.
The main risks are that Film Products still faces difficult market conditions, especially in the first half of 2015, from oversupply and pricing pressure in flexible packaging films. Management also highlighted a meaningful increase in pension expense in 2015 to about $12.3 million, temporary first-quarter disruption from anodizing capacity expansion, and the fact that some of the Film Products weakness was not just one-time noise but related to competitive and operational pressures.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 80.0%
- Shares Outstanding
- 34.90M
- Float Shares
- 27.92M
of shares held by institutions
141 13F filers
Buy/sell ratio 0.47. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Gamco Investors, Inc. Et Al | 5.98M | ▼ 113.49K |
| Blackrock, Inc. | 2.41M | ▲ 137.66K |
| Minerva Advisors LLC | 1.67M | 0 |
| Vanguard Group Inc | 1.54M | ▲ 25.70K |
| Vanguard Capital Management LLC | 1.27M | ▲ 91.00K |
| Gabelli Funds LLC | 1.23M | ▼ 5.00K |
| Dimensional Fund Advisors LP | 1.21M | ▲ 80.69K |
| Geode Capital Management, LLC | 745.02K | ▲ 96.41K |
| State Street Corp | 622.61K | ▼ 35.01K |
| Acadian Asset Management LLC | 569.58K | ▲ 259.78K |
| American Century Companies Inc | 549.87K | ▲ 455.21K |
| Aqr Capital Management LLC | 451.88K | ▲ 365.98K |
Held by 109 ETFs
Biggest fund positions in TG by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 17, 26 | GOTTWALD JOHN D | sell | 7,718 |
| Aug 18, 26 | GOTTWALD JOHN D | sell | 3,472 |
| Aug 17, 26 | GOTTWALD WILLIAM M | sell | 7,718 |
| Aug 18, 26 | GOTTWALD WILLIAM M | sell | 3,472 |
| Aug 17, 26 | Gottwald James T. | sell | 7,719 |
| Aug 18, 26 | Gottwald James T. | sell | 3,472 |
| Aug 18, 26 | DasGupta Arijit | buy | 2,093 |
| Aug 14, 26 | DasGupta Arijit | buy | 907 |
| Aug 13, 26 | GOTTWALD JOHN D | sell | 1,020 |
| Aug 13, 26 | Gottwald James T. | sell | 1,020 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TG coverage
Recent articles, reports, and earnings notes.
No research on TG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TG report →Tredegar Q2 Earnings Rise Y/Y on Aluminum Extrusions Gains
zacks.com · Aug 13
Tredegar (NYSE:TG) Share Price Crosses Above 200 Day Moving Average – Here’s Why
defenseworld.net · Aug 12
Tredegar Reports Second Quarter 2026 Results
businesswire.com · Aug 7
Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026
businesswire.com · Aug 3
Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026
businesswire.com · Jul 30
Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia
gurufocus.com · Jul 22
TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
gurufocus.com · Jun 24
Trifecta Gold Increases Private Placement
accessnewswire.com · Jun 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.